Davis Wright Tremaine LLP is pleased to have advised Ajinomoto Co., Inc., a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals, in its latest strategic acquisition.
Through its North American subsidiary, Ajinomoto closed this month on the acquisition of Cambrooke Therapeutics Inc., a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy.
Portland-based Davis Wright Tremaine lawyers Michael Phillips and Ryan Maughn represented Ajinomoto North America in the deal, the latest in a series of transactions that have expanded the client’s product line and presence in the U.S.